DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,254 filers reported holding DANAHER CORPORATION in Q3 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $479,000 | -10.8% | 1,633 | 0.0% | 0.08% | -4.9% |
| Q4 2021 | $537,000 | +8.0% | 1,633 | 0.0% | 0.08% | -2.4% |
| Q3 2021 | $497,000 | +13.5% | 1,633 | 0.0% | 0.08% | +5.0% |
| Q2 2021 | $438,000 | +19.0% | 1,633 | 0.0% | 0.08% | +9.6% |
| Q1 2021 | $368,000 | +1.4% | 1,633 | 0.0% | 0.07% | -7.6% |
| Q4 2020 | $363,000 | +3.1% | 1,633 | 0.0% | 0.08% | -6.0% |
| Q3 2020 | $352,000 | +21.8% | 1,633 | 0.0% | 0.08% | +13.5% |
| Q2 2020 | $289,000 | +27.9% | 1,633 | 0.0% | 0.07% | +4.2% |
| Q1 2020 | $226,000 | -10.0% | 1,633 | 0.0% | 0.07% | -10.1% |
| Q4 2019 | $251,000 | +5.0% | 1,633 | -1.5% | 0.08% | -16.8% |
| Q3 2019 | $239,000 | +0.8% | 1,658 | 0.0% | 0.10% | -2.1% |
| Q2 2019 | $237,000 | -2.9% | 1,658 | -10.3% | 0.10% | +9.0% |
| Q1 2019 | $244,000 | +27.7% | 1,848 | 0.0% | 0.09% | -5.3% |
| Q4 2018 | $191,000 | -5.0% | 1,848 | 0.0% | 0.09% | +22.1% |
| Q3 2018 | $201,000 | +10.4% | 1,848 | 0.0% | 0.08% | +1.3% |
| Q2 2018 | $182,000 | +0.6% | 1,848 | 0.0% | 0.08% | -6.2% |
| Q1 2018 | $181,000 | -7.2% | 1,848 | -11.9% | 0.08% | -14.7% |
| Q4 2017 | $195,000 | -20.7% | 2,098 | -26.8% | 0.10% | -24.6% |
| Q3 2017 | $246,000 | +1.7% | 2,868 | 0.0% | 0.13% | -0.8% |
| Q2 2017 | $242,000 | -1.2% | 2,868 | 0.0% | 0.13% | -17.5% |
| Q1 2017 | $245,000 | +9.9% | 2,868 | 0.0% | 0.15% | +4.8% |
| Q4 2016 | $223,000 | -47.7% | 2,868 | -47.2% | 0.15% | -50.8% |
| Q3 2016 | $426,000 | -22.3% | 5,428 | 0.0% | 0.30% | -23.9% |
| Q2 2016 | $548,000 | +6.4% | 5,428 | 0.0% | 0.39% | +12.0% |
| Q1 2016 | $515,000 | +2.2% | 5,428 | 0.0% | 0.35% | -3.6% |
| Q4 2015 | $504,000 | +8.9% | 5,428 | 0.0% | 0.36% | +0.6% |
| Q3 2015 | $463,000 | -0.4% | 5,428 | 0.0% | 0.36% | +11.0% |
| Q2 2015 | $465,000 | +0.9% | 5,428 | 0.0% | 0.33% | -4.4% |
| Q1 2015 | $461,000 | -0.9% | 5,428 | 0.0% | 0.34% | +1.5% |
| Q4 2014 | $465,000 | +12.9% | 5,428 | 0.0% | 0.34% | +7.7% |
| Q3 2014 | $412,000 | -3.5% | 5,428 | 0.0% | 0.31% | -4.0% |
| Q2 2014 | $427,000 | +4.9% | 5,428 | 0.0% | 0.32% | -2.4% |
| Q1 2014 | $407,000 | -2.9% | 5,428 | 0.0% | 0.33% | -2.6% |
| Q4 2013 | $419,000 | – | 5,428 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |